News

About 46% of respondents said they somewhat or greatly preferred the idea of being able to choose from a long list of coverage providers and plan types.

Regulators accused the company of failing to make good on earlier promises to improve how it handles complaints.

When cost is removed as an option, the public rank prior authorization as the biggest problem, the latest KFF Heath Tracking Poll found.

"Without real-time supply-chain visibility, teams are forced to make critical decisions with incomplete information." said Jeff Wagner vice president of pharmacy, respiratory care and ECMO services for Texas Children's Hospital.

Demand for obesity and metabolic therapies is accelerating deal activity as pharma companies shift from blockbuster drugs to platform control.

The complaint, filed by the law firm Sanford Heisler Sharp McKnight, alleges that Bloomberg failed to remove two funds from its plan after they performed poorly for more than a decade.